Liver disease | Medibuddy
24th July 2024

Liver disease

Liver disease is a heterogeneous condition with complex interplay between different bleeding and thrombotic mechanisms. It is no longer thought that patients with liver disease are only more prone to bleeding – there is often both a prothrombotic and concomitant pro-bleeding state.

Common haematological derangements in liver disease include:

Platelets Low due to splenic sequestration secondary to portal hypertension, reduced thrombopoietin production by the liver, and bone marrow suppression from infection or alcohol.
Factors V, VII, IX, X and XI Reduced production by the liver, leading to prolonged PT/APTT. Factors VII, IX and X require vitamin K for their production, and in patients who have vitamin K deficiency (e.g. in alcohol dependence or cholestatic liver disease) vitamin K administration may improve levels of some factors. PT/APTT is not necessarily useful in assessing coagulability in the context of liver disease, but it is a key component in the prognostic UK MELD scoring system.
Proteins C and S Reduced production by the liver, which can contribute to a prothrombotic state.

Platelets are often transfused once below 50 x 10-9 but INR is not routinely corrected.

For common procedures encountered in liver disease such as paracentesis, pre-procedure prophylaxis is not routinely recommended owing to the low bleeding risk. Prior to invasive procedures, a discussion between haematologists and hepatologists is advised to assess the overall bleeding/coagulable state of a given patient.

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.